Where does Bruker Cellular Analysis, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bruker Cellular Analysis, Inc. ranks #16,653 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bruker Cellular Analysis, Inc. hold?

Bruker Cellular Analysis, Inc. holds 17 US utility patents granted between 2024 and 2025, spanning 17 technology areas.

What is Bruker Cellular Analysis, Inc.'s Innovation Score?

Bruker Cellular Analysis, Inc. has an Innovation Score of 56.0 out of 100 (top 6% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Bruker Cellular Analysis, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Bruker Cellular Analysis, Inc..

What does claim depth mean for Bruker Cellular Analysis, Inc.'s patents?

Bruker Cellular Analysis, Inc.'s patents average 19.0 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bruker Cellular Analysis, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Bruker Cellular Analysis, Inc.

Q: What technology areas does Bruker Cellular Analysis, Inc. focus on?

Bruker Cellular Analysis, Inc.'s top technology area is B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE) with 11 patents. Grants appear in 17 CPC subclasses total.

USPTO PatentsView assignee record - 17 granted patents across 17 technology areas, recorded in grant years 2024–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE).

Compiled by PlainPatent · May 15, 2026

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bruker ranks #16,653 of 50,000 tracked US assignees by granted-patent volume, with 17 patents across 17 technology areas.

#16,653
of 50,000 US assignees by volume: Top 6%
by Innovation Score (56.0/100): 19.0
avg claims per patent

USPTO PatentsView assignee plate

Corpus R16653 · US Corporation #16,653 · 17 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 17 grants
MID-PACK #16,653/50,000
PHOTO-FINISH Bluefin Labs
CPC-FOCUS B01L · 17 areas
INNOV-PAR 56.0/100
CLAIMS-RICH 19.0 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2024–2025 · 2y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Bluefin Labs, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
Bruker Cellular Anal… · this assignee

56
3D Lighting Innovati… · lowest

7

What this shows Bruker Cellular Analysis, Inc. stamps GRANTS-MICRO, MID-PACK, PHOTO-FINISH, CPC-FOCUS, INNOV-PAR, CLAIMS-RICH, TYPE-USCORP, SPAN-YRS, BOOK-RICH. Volume places it #16,653 of 50,000; Innovation Score 56.0/100 sits in the top 6% of the PatentsView-derived corpus. Closest grant-volume peer on this plate is Bluefin Labs, Inc. (±0 grants).

Portfolio overview

Bruker Cellular Analysis, Inc. has been granted 17 US utility patents between 2024 and 2025, placing Bruker Cellular Analysis, Inc. at #16,653 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 17 distinct Cooperative Patent Classification (CPC) subclasses, averaging 19.0 claims per patent with primary concentration in B01L (CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE). As a US Corporation, Bruker Cellular Analysis, Inc. is one of the more focused assignees in the PatentsView dataset. By volume, Bruker sits between Bluefin Labs, Inc. (17 patents, rank #16,654) and Cambia Health Solutions, Inc. (17 patents, rank #16,662) - the closest US assignees by grant volume. The composite Innovation Score of 56.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Historical data spans 2024 through 2025, with 17 total grants over that period. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The US Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. Bruker Cellular Analysis, Inc.'s 19.0 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 17 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Bluefin Labs

17
Bradken Resources…

17
Bright Energy Sto…

17
Bripco BVBA

17
Buyers Products

17
C-lecta

17
CALB Technology

17
Cambia Health Sol…

17
Bruker Cellular A… ◀

17

What this shows Bruker holds 17 patents at rank #16,658, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bruker

By rank, the assignees closest to #16,658 in granted patent volume.

Leaders in B01L (Chemical OR Physical Laboratory Apparatus FOR General USE)

Other assignees with the most granted patents in Bruker's primary technology class.

Bruker's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

56 Top 6% higher than 94% of 50,000 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2024–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2024–2019 baseline. Full figures in the table below.

View data table

Bruker Cellular Analysis, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2024	12	70.6%
2025partial year	5	29.4%

Which technologies does Bruker Cellular Analysis, Inc. patent most?

B01L - CHEMICAL OR PHYSICAL LABORATORY APPARATUS FOR GENERAL USE 11

C12M - APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS 7

G01N - INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 5

C12N - MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA 3

B03C - MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS 2

C07K - PEPTIDES 2

C12Q - MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS ; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES 2

A01N - PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF ; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES ; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS 1

B01F - MIXING, e.g. DISSOLVING, EMULSIFYING OR DISPERSING 1

C12P - FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1

C40B - COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES 1

B01J - CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS 1

B81B - MICROSTRUCTURAL DEVICES OR SYSTEMS, e.g. MICROMECHANICAL DEVICES 1

B81C - PROCESSES OR APPARATUS SPECIALLY ADAPTED FOR THE MANUFACTURE OR TREATMENT OF MICROSTRUCTURAL DEVICES OR SYSTEMS 1

Y10T - TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION 1

Top 15 of 17 technology areas

Where it ranks

Overall rank by patents

#16,653

of 50,000 tracked assignees

Innovation Score

56.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.